Literature DB >> 19949302

RNAi-induced synthetic lethality in cancer therapy.

Bingbing Dai1, Bingliang Fang, Jack A Roth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19949302      PMCID: PMC4512945          DOI: 10.4161/cbt.8.23.10539

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  20 in total

1.  Protein and peptide transduction, twenty years later a happy birthday.

Authors:  Alain Prochiantz
Journal:  Adv Drug Deliv Rev       Date:  2007-10-22       Impact factor: 15.470

Review 2.  TAT transduction: the molecular mechanism and therapeutic prospects.

Authors:  Jacob M Gump; Steven F Dowdy
Journal:  Trends Mol Med       Date:  2007-10       Impact factor: 11.951

Review 3.  Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development.

Authors:  D D Rao; N Senzer; M A Cleary; J Nemunaitis
Journal:  Cancer Gene Ther       Date:  2009-08-28       Impact factor: 5.987

Review 4.  Molecular mechanisms in gliomagenesis.

Authors:  Esther Hulleman; Kristian Helin
Journal:  Adv Cancer Res       Date:  2005       Impact factor: 6.242

5.  Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway.

Authors:  Yan Wang; Ingo H Engels; Deborah A Knee; Marc Nasoff; Quinn L Deveraux; Kim C Quon
Journal:  Cancer Cell       Date:  2004-05       Impact factor: 31.743

6.  Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.

Authors:  Tim P Hughes; Jaspal Kaeda; Susan Branford; Zbigniew Rudzki; Andreas Hochhaus; Martee L Hensley; Insa Gathmann; Ann E Bolton; Iris C van Hoomissen; John M Goldman; Jerald P Radich
Journal:  N Engl J Med       Date:  2003-10-09       Impact factor: 91.245

7.  Patterns of somatic mutation in human cancer genomes.

Authors:  Christopher Greenman; Philip Stephens; Raffaella Smith; Gillian L Dalgliesh; Christopher Hunter; Graham Bignell; Helen Davies; Jon Teague; Adam Butler; Claire Stevens; Sarah Edkins; Sarah O'Meara; Imre Vastrik; Esther E Schmidt; Tim Avis; Syd Barthorpe; Gurpreet Bhamra; Gemma Buck; Bhudipa Choudhury; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kris Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jon Hinton; Andy Jenkinson; David Jones; Andy Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; Dave Richardson; Rebecca Shepherd; Alexandra Small; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; Daniel P Cahill; David N Louis; Peter Goldstraw; Andrew G Nicholson; Francis Brasseur; Leendert Looijenga; Barbara L Weber; Yoke-Eng Chiew; Anna DeFazio; Mel F Greaves; Anthony R Green; Peter Campbell; Ewan Birney; Douglas F Easton; Georgia Chenevix-Trench; Min-Han Tan; Sok Kean Khoo; Bin Tean Teh; Siu Tsan Yuen; Suet Yi Leung; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

8.  A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.

Authors:  Ji Luo; Michael J Emanuele; Danan Li; Chad J Creighton; Michael R Schlabach; Thomas F Westbrook; Kwok-Kin Wong; Stephen J Elledge
Journal:  Cell       Date:  2009-05-29       Impact factor: 41.582

Review 9.  Knocking down barriers: advances in siRNA delivery.

Authors:  Kathryn A Whitehead; Robert Langer; Daniel G Anderson
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694

Review 10.  Mechanisms of disease: genetic predictors of response to treatment in brain tumors.

Authors:  V Peter Collins
Journal:  Nat Clin Pract Oncol       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.